(NASDAQ:LENZ), Launched VIZZ(TM) (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with over 20,000 prescriptions filled in Q4 2025 Over 6,500 unique ECPs prescribed VIZZ; more than 55% have prescribed multiple times in Q4 2025 SAN […]

LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates GlobeNewswire January 07, 2026 Launched VIZZ(TM) (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with over 20,000 prescriptions filled in Q4 2025

Vancouver, British Columbia–(Newsfile Corp. – January 7, 2026) – Battery Mineral Resources Corp. (TSXV: BMR) (OTCQB: BTRMF) (“Battery” or “BMR” or the “Company“) is pleased to announce that it intends to complete a non-brokered private placement of 174,430,850 common shares of the Company (“Common Shares“) at a price of C$0.20 (USD$0.145) per Common Share for

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ:GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the "Class Period"), of the important February 6, 2026 lead plaintiff deadline. SO WHAT:

Toronto, Ontario–(Newsfile Corp. – January 7, 2026) – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) (“Aurania” or the “Company”) announces that its annual letter to shareholders from Chairman, President and CEO, Dr. Keith Barron is now available. To view the full letter in PDF format on Aurania’s website, click here. “Over the past

Vancouver, British Columbia–(Newsfile Corp. – January 7, 2026) – Barksdale Resources Corp. (TSXV: BRO) (OTCQB: BRKCF) (FSE: 2NZ) (“Barksdale” or the “Company“) announces that its new omnibus share incentive plan (the “Share Incentive Plan“) has been approved by the TSX Venture Exchange (the “TSXV“). The Share Incentive Plan was previously adopted by the board of

(NYSE:ORC), January 2026 Monthly Dividend of $0.12 Per Share of Common Stock Estimated Fourth Quarter 2025 Results and MBS Portfolio Characteristics as of December 31, 2025 to be Released January 14, 2026 Year End and Fourth Quarter 2025 Results to be Released January 29, 2026 VERO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — Orchid

Orchid Island Capital Announces January 2026 Monthly Dividend and Fourth Quarter 2025 Results Announcement Dates GlobeNewswire January 07, 2026 January 2026 Monthly Dividend of $0.12 Per Share of Common Stock Estimated Fourth Quarter 2025 Results and MBS Portfolio Characteristics as of December 31, 2025 to be Released January 14, 2026 Year End and Fourth Quarter

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in cryptocurrency issued by Balancer (ticker:BAL), resulting from allegations that Balancer may have issued materially misleading business information to the investing public. SO

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Alvotech (NASDAQ:ALVO) resulting from allegations that Alvotech may have issued materially misleading business information to the investing public. SO WHAT: If you